Hematology and Oncology in Critical Illness

[1]  S. Orkin,et al.  Nathan and Oski's hematology of infancy and childhood , 2013 .

[2]  B. Jilma,et al.  A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura , 2011, Thrombosis and Haemostasis.

[3]  C. Esmon,et al.  Innate immunity and coagulation , 2011, Journal of Thrombosis and Haemostasis.

[4]  Scott T. Miller,et al.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) , 2011, The Lancet.

[5]  C. Pui,et al.  The tumor lysis syndrome. , 2011, The New England journal of medicine.

[6]  R. McKinstry,et al.  Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. , 2011, Blood.

[7]  T. Ortel,et al.  The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion , 2010, Journal of thrombosis and haemostasis : JTH.

[8]  B. Coiffier,et al.  Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus , 2010, British journal of haematology.

[9]  H. Gurnaney,et al.  Anesthetic management of children with an anterior mediastinal mass. , 2010, Journal of clinical anesthesia.

[10]  H. Hasle,et al.  Nathan and Oski’s Hematology of Infancy and Childhood , 2010 .

[11]  C. Feudtner,et al.  Dramatic Increase in Venous Thromboembolism in Children's Hospitals in the United States From 2001 to 2007 , 2009, Pediatrics.

[12]  T. Alonzo,et al.  Disseminated intravascular coagulation score is associated with mortality for children with shock , 2009, Intensive Care Medicine.

[13]  Edward Y Lee,et al.  Management of children and adolescents with a critical airway due to compression by an anterior mediastinal mass. , 2008, Journal of pediatric surgery.

[14]  P. Monagle,et al.  Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies , 2008, Circulation.

[15]  A. Randolph,et al.  Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. , 2008, American journal of respiratory and critical care medicine.

[16]  C. Pui,et al.  Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Sanz,et al.  Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model , 2008, Haematologica.

[18]  C. Pui,et al.  Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses , 2007, Paediatric anaesthesia.

[19]  Pulmonary hypertension in sickle cell disease. , 2007, Clinical advances in hematology & oncology : H&O.

[20]  D. Angus.  Caring for the critically ill patient: challenges and opportunities. , 2007, JAMA.

[21]  J. Collet,et al.  Transfusion strategies for patients in pediatric intensive care units. , 2007, The New England journal of medicine.

[22]  C. Sigouin,et al.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings , 2006, Journal of thrombosis and haemostasis : JTH.

[23]  R. Nagel,et al.  Sickle-cell disease , 2004, The Lancet.

[24]  P. Stein,et al.  Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. , 2004, The Journal of pediatrics.

[25]  M. Cairo,et al.  Tumour lysis syndrome: new therapeutic strategies and classification , 2004, British journal of haematology.

[26]  J. Bussel,et al.  Differential diagnosis and management of thrombocytopenia in childhood. , 2004, Pediatric clinics of North America.

[27]  M. Fink.  Pathophysiology of intensive care unit-acquired anemia , 2004, Critical care.

[28]  T. Warkentin.  An overview of the heparin-induced thrombocytopenia syndrome. , 2004, Seminars in thrombosis and hemostasis.

[29]  Naveen D. Bhandarkar,et al.  Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. , 2004, The American journal of medicine.

[30]  G. Tasopoulos,et al.  A new way of noninvasive ventilation in ICU patients. An innovation modification of the continuous positive airway pressure (CPAP) face mask Boussignac–Vygon in order to use it in chronic obstructive pulmonary disease (COPD) (type II) patients , 2004 .

[31]  M. Levi.  Current understanding of disseminated intravascular coagulation , 2004, British journal of haematology.

[32]  T. van der Poll,et al.  New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology , 2004, Annals of medicine.

[33]  M. Peters,et al.  Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome , 2003, Journal of thrombosis and haemostasis : JTH.

[34]  Arvind K. Shah,et al.  Causes of death in sickle cell disease: an autopsy study , 2003, British journal of haematology.

[35]  C. Vermylen.  Hematopoietic stem cell transplantation in sickle cell disease. , 2003, Blood reviews.

[36]  Tomas Ganz,et al.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. , 2003, Blood.

[37]  C. Sprung,et al.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. , 2003, JAMA.

[38]  T. Iba,et al.  [Disseminated intravascular coagulation]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[39]  S. Revel-Vilk,et al.  Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease 1 , 2003, Journal of thrombosis and haemostasis : JTH.

[40]  W. Ouwehand,et al.  Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy , 2003, British journal of haematology.

[41]  M. Pollack,et al.  Pediatric red blood cell transfusions increase resource use. , 2003, The Journal of pediatrics.

[42]  P. Monahan,et al.  Thrombosis in Children: Current Perspective and Distinct Challenges , 2002, Thrombosis and Haemostasis.

[43]  M. Hermiston,et al.  A practical approach to the evaluation of the anemic child. , 2002, Pediatric clinics of North America.

[44]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[45]  S. Opal,et al.  High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .

[46]  O'Connor Pe.  Recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[47]  U. Nowak‐Göttl,et al.  Thromboembolism in Newborns, Infants and Children , 2001, Thrombosis and Haemostasis.

[48]  M. Cairo,et al.  A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. , 2001, Blood.

[49]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[50]  S. Weinberger,et al.  Thrombocytopenic disorders in critically ill patients. , 2000, American journal of respiratory and critical care medicine.

[51]  P. V. Ichinsky,et al.  Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease , 2000 .

[52]  D. Malkin,et al.  The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma. , 2000, Journal of pediatric surgery.

[53]  S. Israels,et al.  Outcome of Pediatric Thromboembolic Disease: A Report from the Canadian Childhood Thrombophilia Registry , 2000, Pediatric Research.

[54]  C. Pegelow,et al.  Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. , 2000, Blood.

[55]  D. Powars.  Management Of Cerebral Vasculopathy In Children With Sickle Cell Anaemia , 2000, British journal of haematology.

[56]  Scott T. Miller,et al.  Prediction of adverse outcomes in children with sickle cell disease. , 2000, The New England journal of medicine.

[57]  M. Andrew,et al.  Venous thromboembolic events in pediatric patients. Diagnosis and management. , 1998, Hematology/oncology clinics of North America.

[58]  W. Kreuz,et al.  Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism , 1996, European Journal of Pediatrics.

[59]  J. George,et al.  Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. , 1996, Blood.

[60]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[61]  N. T. Griscom,et al.  Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses. , 1995, Surgery.

[62]  R. Hoffman,et al.  Hematology: Basic Principles and Practice , 1995 .

[63]  M. Bernstein,et al.  Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE , 1994 .

[64]  J. Stockman.  Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease , 2011 .

[65]  J. Avorn.  Eculizumab in Severe Shiga-Toxin-Associated HUS , 2011 .

[66]  A. Pession,et al.  Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy. , 2005, Haematologica.

[67]  L. Risch,et al.  Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. , 2002, Pediatrics.

[68]  S. Opal,et al.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. , 2001, JAMA.

[69]  E. Vichinsky,et al.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. , 2000, The New England journal of medicine.

[70]  J. George,et al.  Drug-induced thrombocytopenia: a systematic review of published case reports. , 1998, Annals of internal medicine.

[71]  Rm,et al.  Sickle cell disease , 1996 .

[72]  Y. Yawata.  [Hemolytic anemia]. , 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[73]  J. Stuart,et al.  Management of sickle-cell disease , 1974, Journal of clinical pathology. Supplement.